New research suggests that adopting some of the strategies behind successfully treating the childhood disease of spinal muscular atrophy may enable the development of therapies to curb the muscle decline that accompanies aging. The research poster was presented at Neuroscience 2022, the annual meeting of the Society for Neuroscience.
About the Author
